Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACC017 in Treatment-Naïve Adults With HIV-1
NCT07711223Phase 2Recruiting
- Sponsor
- Aidea Pharma
- Start
- Nov 2025
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
A Phase 2 trial of asuptegravir in human immunodeficiency virus infection (HIV), sponsored by Aidea Pharma. Started Nov 2025; status: recruiting.
02
Drugs
asuptegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07711223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711223.